Literature DB >> 12655562

Identification of six novel MSH2 and MLH1 germline mutations in HNPCC.

Stefan Krüger1, Jens Plaschke, Birgit Jeske, Heike Görgens, Steffen R Pistorius, Andrea Bier, Friedmar R Kreuz, Franz Theissig, Daniela E Aust, Hans D Saeger, Hans K Schackert.   

Abstract

Germline mutations in mismatch repair genes are responsible for hereditary nonpolyposis colorectal cancer (HNPCC), the most common hereditary cancer-susceptibility syndrome. We report six novel germline mutations, three in MSH2 and three in MLH1. All but one mutation have been found in families fulfilling the criteria of the Bethesda guidelines; two of them additionally fulfilled the Amsterdam criteria. We identified two nonsense mutations in MSH2 (c.1764T>G [p.Y588X], c.2579C>A [p.S860X]), one duplication of four nucleotides causing premature stop codon (MLH1: c.821_824dupAAGC [p.A275fsX307]), one splice site mutation resulting in skipping of exon 8 from the MLH1 transcript (c.677+3A>G), one duplication of 18 nucleotides leading to duplication of six amino acids in the mismatch-binding domain of MSH2 (c.4_21dup [p.A2_E7dup) and one missense mutation in the PMS2 interaction domain of MLH1 (c.1756G>C [p.A586P]). The three latter mutations were not found in 73, 90 and 94 healthy control individuals, respectively. The corresponding tumors from all patients showed a high level of microsatellite instability (MSI-H). Immunohistochemistry (IH) revealed complete loss of expression of the affected protein in the tumor cells from the patients with the nonsense, splice-site and missense mutation. The tumor from the patient with the c.821_824dupAAGC mutation showed a reduced, rather than lost, expression of the MLH1-protein. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655562     DOI: 10.1002/humu.9121

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

1.  Microsatellite stable colorectal cancers in clinically suspected hereditary nonpolyposis colorectal cancer patients without vertical transmission of disease are unlikely to be caused by biallelic germline mutations in MYH.

Authors:  Heike Görgens; Stefan Krüger; Eberhard Kuhlisch; Constanze Pagenstecher; Ruth Höhl; Hans K Schackert; Annegret Müller
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

2.  Truncation of the MSH2 C-terminal 60 amino acids disrupts effective DNA mismatch repair and is causative for Lynch syndrome.

Authors:  Eva Wielders; Elly Delzenne-Goette; Rob Dekker; Martin van der Valk; Hein Te Riele
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

3.  Meta-analysis of Genetic Structure and Association of Prolactin Gene with Performance Traits in Dairy Cattle in India.

Authors:  Yogesh C Bangar; A Magotra; C S Patil; N Jindal
Journal:  Biochem Genet       Date:  2021-01-27       Impact factor: 1.890

4.  Genetic detection of Chinese hereditary nonpolyposis colorectal cancer.

Authors:  Long Cui; Hei-Ying Jin; Hui-Yu Cheng; Yu-Di Yan; Rong-Gui Meng; De-Hong Yu
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

5.  Determination of splice-site mutations in Lynch syndrome (hereditary non-polyposis colorectal cancer) patients using functional splicing assay.

Authors:  Hiromu Naruse; Noriko Ikawa; Kiyoshi Yamaguchi; Yusuke Nakamura; Masami Arai; Chikashi Ishioka; Kokichi Sugano; Kazuo Tamura; Naohiro Tomita; Nagahide Matsubara; Teruhiko Yoshida; Yoshihiro Moriya; Yoichi Furukawa
Journal:  Fam Cancer       Date:  2009-08-15       Impact factor: 2.375

6.  Identification and analysis of biomarkers for mismatch repair proteins: A bioinformatic approach.

Authors:  Manika Sehgal; Tiratha Raj Singh
Journal:  J Nat Sci Biol Med       Date:  2012-07

7.  Functional examination of MLH1, MSH2, and MSH6 intronic mutations identified in Danish colorectal cancer patients.

Authors:  Sanne M Petersen; Mette Dandanell; Lene J Rasmussen; Anne-Marie Gerdes; Lotte N Krogh; Inge Bernstein; Henrik Okkels; Friedrik Wikman; Finn C Nielsen; Thomas V O Hansen
Journal:  BMC Med Genet       Date:  2013-10-03       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.